Correction: Risk of Death and Cardiovascular Outcomes with Thiazolidinediones: A Study with the General Practice Research Database and Secondary Care Data.

Correction: Risk of Death and Cardiovascular Outcomes with Thiazolidinediones: A Study with the General Practice Research Database and Secondary Care Data.

Bibliographic Details
Main Authors:	Arlene M. Gallagher, Liam Smeeth, Suzie Seabroke, Hubert G. M. Leufkens, Tjeerd P. van Staa
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3894296

Similar Items

Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data.
by: Arlene M Gallagher, et al.
Published: (2011-01-01)

Risk of fracture with thiazolidinediones: an individual patient data meta-analysis
by: Marloes T Bazelier, et al.
Published: (2013-02-01)

Use of Thiazolidinediones and Risk of Osteoporotic Fracture: The Danish National Databases
by: Bazelier, M, et al.
Published: (2011)

Correction: Risk of Death and Cardiovascular Outcomes with Thiazolidinediones: A Study with the General Practice Research Database and Secondary Care Data
Published: (2013-01-01)

Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
by: Bazelier, M, et al.
Published: (2012)

Use of Thiazolidinediones and Risk of Osteoporotic Fracture: Disease or Drugs?
by: Bazelier, M, et al.
Published: (2011)

A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example.
by: Tjeerd-Pieter van Staa, et al.
Published: (2009-12-01)

USE OF THIAZOLIDINEDIONES AND RISK OF OSTEOPOROTIC FRACTURE: DISEASE OR DRUGS?
by: Bazelier, M, et al.
Published: (2010)

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study.
by: Ian J Douglas, et al.
Published: (2009-09-01)

Use of thiazolidinediones and risk of osteoporotic fracture Disease or drugs?
by: de Vries, F, et al.
Published: (2010)

Type 2 diabetes, thiazolidinediones, and cardiovascular risk.
by: Taylor, C, et al.
Published: (2009)

Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
by: Tjeerd-Pieter van Staa, et al.
Published: (2014-01-01)

Cancer recording in patients with type 2 diabetes in primary care and hospital admission data
by: Rachael Williams, et al.
Published: (2017-04-01)

Effect of thiazolidinediones on insulin resistance and cardiovascular risk factors
by: T Yu Demidova, et al.
Published: (2008-06-01)

Thiazolidinedione and cardiovascular risk in type 2 diabetes mellitus
by: Yenny Yenny
Published: (2016-04-01)

USE OF THIAZOLIDINEDIONES AND RISK OF OSTEOPOROTIC FRACTURE: DISEASE OR DRUGS?
by: Bazelier, M, et al.
Published: (2012)

Epidemiology of childhood fractures in Britain: a study using the general practice research database.
by: Cooper, C, et al.
Published: (2004)

Thiazolidinedione, friend or foe?
by: Sachan A
Published: (2016-04-01)

Randomised Evaluations of Accepted Choices in Treatment (REACT) trials: large-scale pragmatic trials within databases of routinely collected electronic healthcare records
by: van Staa Tjeerd-Pieter, et al.
Published: (2011-12-01)

The risk of fracture in patients with multiple sclerosis: the UK general practice research database.
by: Bazelier, M, et al.
Published: (2011)

A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications
by: Behzad Molavi, et al.
Published: (2008-01-01)

Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database
by: de Vries, F, et al.
Published: (2006)

Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database.
by: de Vries, F, et al.
Published: (2006)

Challenges in drug discovery for thiazolidinedione substitute
by: Jian-ping Ye
Published: (2011-10-01)

Thiazolidinedione induced thyroid associated orbitopathy
by: McCann John D, et al.
Published: (2007-04-01)

Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma
by: Meei-Ling Sheu, et al.
Published: (2022-11-01)

Oldies but Goodies: Thiazolidinedione as an Insulin Sensitizer with Cardioprotection
by: Eun-Hee Cho
Published: (2022-11-01)

Biological potential of thiazolidinedione derivatives of synthetic origin
by: Sucheta, et al.
Published: (2017-12-01)

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
by: Chang Ho Ahn, et al.
Published: (2019-05-01)

Factors associated with results and conclusions of trials of thiazolidinediones.
by: Gail Rattinger, et al.
Published: (2009-06-01)

Correction to: The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care
by: Alexander Pate, et al.
Published: (2019-08-01)

Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones
by: Andrea Benova, et al.
Published: (2022-11-01)

The Impact of the Choice of Data Source in Record Linkage Studies Estimating Mortality in Venous Thromboembolism.
by: Arlene M Gallagher, et al.
Published: (2016-01-01)

Thiazolidinediones are associated with a reduced risk of COPD exacerbations
by: Rinne ST, et al.
Published: (2015-08-01)

Redefining the role of thiazolidinediones in the management of type 2 diabetes
by: Anthony H Barnett
Published: (2009-01-01)

Synthesis, characterization and antimicrobial evaluation of imidazolyl thiazolidinedione derivatives
by: Perumal Moorthy, et al.
Published: (2019-03-01)

The effect of metformin and thiazolidinedione use on lung cancer in diabetics
by: Mazzone Peter J, et al.
Published: (2012-09-01)

Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.
by: Dongfeng Zhao, et al.
Published: (2014-01-01)

Patterns of risk of cancer in patients with metal-on-metal hip replacements versus other bearing surface types: a record linkage study between a prospective joint registry and general practice electronic health records in England.
by: Arief Lalmohamed, et al.
Published: (2013-01-01)

Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators
by: Domenica M. Corigliano, et al.
Published: (2018-08-01)